| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,927 |
22,777 |
$1.11M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,761 |
12,052 |
$976K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,523 |
5,083 |
$246K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,281 |
9,003 |
$159K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,239 |
1,174 |
$99K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,888 |
1,717 |
$59K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,903 |
1,752 |
$46K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,668 |
1,209 |
$42K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
684 |
592 |
$27K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
838 |
665 |
$24K |
| 81025 |
|
5,432 |
4,635 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
351 |
307 |
$18K |
| 81002 |
|
6,781 |
5,901 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
218 |
189 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
933 |
754 |
$13K |
| 87428 |
|
181 |
170 |
$11K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
856 |
801 |
$8K |
| 87807 |
|
305 |
266 |
$3K |
| 87634 |
|
52 |
49 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
135 |
124 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
99 |
89 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$942.65 |
| 69209 |
|
31 |
26 |
$316.19 |
| 82962 |
|
170 |
139 |
$310.30 |
| 99459 |
|
16 |
16 |
$233.92 |
| 90686 |
|
13 |
13 |
$171.61 |
| 81003 |
|
67 |
57 |
$146.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
67 |
45 |
$102.54 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
365 |
278 |
$48.76 |
| 36415 |
Collection of venous blood by venipuncture |
228 |
223 |
$40.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
24 |
$36.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
13 |
$18.91 |